Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT06696079

Restarting Early Versus Later Anticoagulation for Chronic Subdural Hematoma With Atrial Fibrillation

Led by Rahul Raj · Updated on 2025-08-22

332

Participants Needed

6

Research Sites

99 weeks

Total Duration

On this page

Sponsors

R

Rahul Raj

Lead Sponsor

T

Tampere University Hospital

Collaborating Sponsor

AI-Summary

What this Trial Is About

The goal of this randomized clinical trial is to assess the benefit of early resumption versus late resumption of oral anticoagulation medication in adults with atrial fibrillation undergoing surgery for chronic subdural hematoma. The main questions it aims to answer are: * Does anticoagulation resumption 5 days after surgery as compared to 30 days after surgery result in fewer thromboembolic complications, without increasing the risk for bleeding? * Does anticoagulation resumption 5 days after surgery as compared to 30 days after surgery affect the risk of reoperation, functional outcome, mortality, and healthcare use? Researchers will compare early anticoagulation resumption (5 days) and late anticoagulation resumption (30 days) after chronic subdural hematoma surgery. Participants will either resume the medication 5 days or 30 days after the surgery. The participants will be followed up for 3 months after the surgery.

CONDITIONS

Official Title

Restarting Early Versus Later Anticoagulation for Chronic Subdural Hematoma With Atrial Fibrillation

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 18 years or older
  • Symptomatic unilateral or bilateral chronic subdural hematoma requiring burr-hole evacuation with drainage
  • Chronic subdural hematoma is mainly hypodense or isodense on CT or MRI imaging
  • Clinical symptoms are attributable to the chronic subdural hematoma
  • Patients on oral anticoagulation medication for permanent, persistent, or paroxysmal spontaneous atrial fibrillation
  • Randomization performed within 4 days after surgery
Not Eligible

You will not qualify if you...

  • Intraoperative or immediate postoperative bleeding complications
  • Chronic subdural hematoma requiring surgical treatment other than burr-hole evacuation, such as craniotomy
  • Prior chronic subdural hematoma surgery within the past 12 months
  • Presence of cerebrospinal fluid shunt
  • Chronic subdural hematoma located in an arachnoid cyst
  • Operated hematoma found to be cerebrospinal fluid collection (hygroma)
  • Conditions other than atrial fibrillation requiring anticoagulation, including therapeutic doses of low molecular-weight heparin or heparin (e.g., pulmonary embolism, deep vein thrombosis, hypercoagulability syndromes)
  • Mechanical heart valves
  • Moderate or severe mitral stenosis (other valvular diseases and biological valves are allowed)
  • Contraindication to anticoagulation medication, such as bleeding disorders, high fall risk (e.g., severe alcoholism), severe thrombocytopenia, or severe anemia
  • Concurrent use of antiplatelet medication
  • Moderate to severe kidney failure (creatinine clearance less than 30 ml/min or on dialysis)
  • Not a permanent resident in Finland (for Finnish patients) or Region Stockholm (for Swedish patients)

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 6 locations

1

Oulu University Hospital

Oulu, North Ostrobothnia, Finland, 90220

Not Yet Recruiting

2

Kuopio University Hospital

Kuopio, Northern Savonia, Finland, 70200

Not Yet Recruiting

3

Tampere University Hospital

Tampere, Pirkanmaa, Finland, 33520

Not Yet Recruiting

4

Turku University Hospital

Turku, Southwest Finland, Finland, 20520

Not Yet Recruiting

5

Helsinki University Hospital

Helsinki, Uusimaa, Finland, 00260

Actively Recruiting

6

Karolinska University Hospital

Stockholm, Region Stockholm, Sweden, 17164

Not Yet Recruiting

Loading map...

Research Team

R

Rahul Raj, MD, PhD

CONTACT

J

Jarno Satopää, MD, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here